相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insulin resistance aggravates atherosclerosis by reducing vascular smoothmuscle cell survival and increasing CX3CL1/CX3CR1 axis
Sergio Martinez-Hervas et al.
CARDIOVASCULAR RESEARCH (2014)
Plasma CX3CL1 Levels and Long Term Outcomes of Patients with Atrial Fibrillation: The West Birmingham Atrial Fibrillation Project
Yutao Guo et al.
CEREBROVASCULAR DISEASES (2014)
Fractalkine levels are elevated early after PCI-treated ST-elevation myocardial infarction; no influence of autologous bone marrow derived stem cell injection
Ida Unhammer Njerve et al.
CYTOKINE (2014)
CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke
Zhiwei Tang et al.
JOURNAL OF NEUROINFLAMMATION (2014)
The temporal dynamics of plasma fractalkine levels in ischemic stroke: association with clinical severity and outcome
Gerrit M. Grosse et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Atorvastatin Improves Plaque Stability in ApoE-Knockout Mice by Regulating Chemokines and Chemokine Receptors
Peng Nie et al.
PLOS ONE (2014)
The Chemokine Fractalkine Can Activate Integrins without CX3CR1 through Direct Binding to a Ligand-Binding Site Distinct from the Classical RGD-Binding Site
Masaaki Fujita et al.
PLOS ONE (2014)
Fractalkine promotes platelet activation and vascular dysfunction in congestive heart failure
Steven K. Hildemann et al.
THROMBOSIS AND HAEMOSTASIS (2014)
Circulating Fractalkine Levels Predict the Development of the Metabolic Syndrome
Yin Xueyao et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients
Thomas R. Cimato et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2014)
Inflammatory effects of resistin on human smooth muscle cells: up-regulation of fractalkine and its receptor, CX3CR1 expression by TLR4 and Gi-protein pathways
Ana-Maria Gan et al.
CELL AND TISSUE RESEARCH (2013)
High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells
Emiel P. C. van der Vorst et al.
FASEB JOURNAL (2013)
CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice
Stefano Fumagalli et al.
GLIA (2013)
Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium
Cristina Rius et al.
THORAX (2013)
Platelet chemokines in health and disease
Ela Karshovska et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Contribution of Platelet CX3CR1 to Platelet-Monocyte Complex Formation and Vascular Recruitment During Hyperlipidemia
Otilia Postea et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Fractalkine Activates a Signal Transduction Pathway Similar to P2Y12 and Is Associated With Impaired Clopidogrel Responsiveness
Ulrike Flierl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Development and characterization of an aptamer binding ligand of fractalkine using domain targeted SELEX
Brett Waybrant et al.
CHEMICAL COMMUNICATIONS (2012)
Therapeutic potential of the chemokine-receptor duo fractalkine/CX3CR1: an update
Jan G. D'Haese et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Integrins αvβ3 and α4β1 Act as Coreceptors for Fractalkine, and the Integrin-Binding Defective Mutant of Fractalkine Is an Antagonist of CX3CR1
Masaaki Fujita et al.
JOURNAL OF IMMUNOLOGY (2012)
Fractalkine Is Expressed in Early and Advanced Atherosclerotic Lesions and Supports Monocyte Recruitment via CX3CR1
Moritz Stolla et al.
PLOS ONE (2012)
Higher Plasma Fractalkine Is Associated With Better 6-Month Outcome From Ischemic Stroke
Megan M. Donohue et al.
STROKE (2012)
Fractalkine is an independent predictor of mortality in patients with advanced heart failure
Bernhard Richter et al.
THROMBOSIS AND HAEMOSTASIS (2012)
The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins
Belinda A. Di Bartolo et al.
ATHEROSCLEROSIS (2011)
The CX3C chemokine fractalkine mediates platelet adhesion via the von Willebrand receptor glycoprotein Ib
Sascha Meyer dos Santos et al.
BLOOD (2011)
In vivo structure/function and expression analysis of the CX3C chemokine fractalkine
Ki-Wook Kim et al.
BLOOD (2011)
Fractalkine Is a Novel Human Adipochemokine Associated With Type 2 Diabetes
Rachana Shah et al.
DIABETES (2011)
Fractalkine and its receptor, CX3CR1, promote hypertensive interstitial fibrosis in the kidney
Kazuaki Shimizu et al.
HYPERTENSION RESEARCH (2011)
Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression
Stephane Potteaux et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
Mibel M. Pabon et al.
JOURNAL OF NEUROINFLAMMATION (2011)
The immune system in atherosclerosis
Goran K. Hansson et al.
NATURE IMMUNOLOGY (2011)
Platelets in atherosclerosis
Dirk Lievens et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Platelet activation and induction of tissue factor in acute and chronic atrial fibrillation: Involvement of mononuclear cell-platelet interaction
Mutsuharu Hayashi et al.
THROMBOSIS RESEARCH (2011)
Platelets and the immune continuum
John W. Semple et al.
NATURE REVIEWS IMMUNOLOGY (2011)
High-Density Lipoproteins Suppress Chemokines and Chemokine Receptors In Vitro and In Vivo
Christina A. Bursill et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling
Gemma E. White et al.
CARDIOVASCULAR RESEARCH (2010)
Upregulation of Fractalkine and Its Receptor, CX3CR1, is Associated With Coronary Plaque Rupture in Patients With Unstable Angina Pectoris
Hideyuki Ikejima et al.
CIRCULATION JOURNAL (2010)
Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential
Jan G. D'Haese et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Fractalkine/CX3CL1: A Potential New Target for Inflammatory Diseases
Brian A. Jones et al.
MOLECULAR INTERVENTIONS (2010)
Interaction of Platelets and Inflammatory Endothelium in the Development and Progression of Coronary Artery Disease
Harald F. Langer et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2010)
Constitutive Endocytosis of the Chemokine CX3CL1 Prevents Its Degradation by Cell Surface Metalloproteases
Yi-Wei Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Functional Adhesiveness of the CX3CL1 Chemokine Requires Its Aggregation ROLE OF THE TRANSMEMBRANE DOMAIN
Patricia Hermand et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse
Adam Denes et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure
Cathrine Husberg et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Circulating platelet-leukocyte aggregates: A marker of microvascular injury in diabetic patients
I. Etalamy et al.
THROMBOSIS RESEARCH (2008)
Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood -: A critical role for P-selectin expressed on activated platelets
Christian Schulz et al.
CIRCULATION (2007)
Atherogenic lipids induce adhesion of human coronary artery smooth muscle cells to macrophages by up-regulating chemokine CX3CL1 on smooth muscle cells in a TNFα-NFκB-dependent manner
Jana Barlic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Improved endothelial function and reduced platelet activation by chronic HMG-CoA-reductase inhibition with rosuvastatin in rats with streptozotocin-induced diabetes mellitus
Andreas Schaefer et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates
Giuseppe Lippi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy
JK Damås et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Rosuvastatin reduces platelet activation in heart failure -: Role of NO bioavailability
A Schäfer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium
P von Hundelshausen et al.
BLOOD (2005)
Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion
A Schäfer et al.
BLOOD (2004)
Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root
D Teupser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack
DJH McCabe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1)
AD Lucas et al.
CIRCULATION (2003)
Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice
JW Phillips et al.
CIRCULATION (2003)
Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice
C Combadière et al.
CIRCULATION (2003)
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
YQ Huo et al.
NATURE MEDICINE (2003)
A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation
S Massberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus
S Nomura et al.
JOURNAL OF HUMAN HYPERTENSION (2002)
Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction
MI Furman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin - Studies in baboons, human coronary intervention, and human acute myocardial infarction
AD Michelson et al.
CIRCULATION (2001)
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis
DH McDermott et al.
CIRCULATION RESEARCH (2001)
分享论文
